Impact of neuroendocrine morphology on cancer outcomes and stage at diagnosis: A UK nationwide cohort study 2013–2015 by Genus, TSE, Bouvier, C, Wong, KF, Srirajaskanthan, R, Rous, BA, Talbot, DC, Valle, JW, Khan, M, Pearce, N, Elshafie, M, Reed, NS, Morgan, E, Deas, A, White, C, Huws, D, Ramage, J

Patterns of progression, treatment of progressive disease and post-progression survival in the New EPOC study by Pugh, SA, Bowers, M, Ball, A, Falk, S, Finch-Jones, M, Valle, JW, O'Reilly, DA, Siriwardena, AK, Hornbuckle, J, Rees, M, Rees, C, Iveson, T, Hickish, T, Maishman, T, Stanton, L, Dixon, E, Corkhill, A, Radford, M, Garden, OJ, Cunningham, D, Maughan, TS, Bridgewater, JA, Primrose, JN

Systemic chemotherapy with or without cetuximab in patients with resectable colorectal liver metastasis (New EPOC): Long-term results of a multicentre, randomised, controlled, phas... by Bridgewater, JA, Pugh, SA, Maishman, T, Eminton, Z, Mellor, J, Whitehead, A, Stanton, L, Radford, M, Corkhill, A, Griffiths, GO, Falk, S, Valle, JW, O'Reilly, D, Siriwardena, AK, Hornbuckle, J, Rees, M, Iveson, TJ, Hickish, T, Garden, OJ, Cunningham, D, Maughan, TS, Primrose, JN, Brown, E